{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:41:47Z","timestamp":1768736507843,"version":"3.49.0"},"reference-count":47,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7,1]]},"DOI":"10.1210\/jc.2007-0282","type":"journal-article","created":{"date-parts":[[2007,4,11]],"date-time":"2007-04-11T02:43:39Z","timestamp":1176259419000},"page":"2453-2461","source":"Crossref","is-referenced-by-count":71,"title":["Comparison of Ethinyl-Estradiol Plus Cyproterone Acetate<i>Versus<\/i>Metformin Effects on Classic Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"92","author":[{"given":"Manuel","family":"Luque-Rami\u0301rez","sequence":"first","affiliation":[{"name":"Departments of Endocrinology (M.L.-R., F.A.-B., J.I.B.-C., E.M.-B., H.F.E.-M.), Hospital Universitario Ramo\u0301n y Cajal and Universidad de Alcala\u0301, E-28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"A\u0301lvarez-Blasco","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (M.L.-R., F.A.-B., J.I.B.-C., E.M.-B., H.F.E.-M.), Hospital Universitario Ramo\u0301n y Cajal and Universidad de Alcala\u0301, E-28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose\u0301 I.","family":"Botella-Carretero","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (M.L.-R., F.A.-B., J.I.B.-C., E.M.-B., H.F.E.-M.), Hospital Universitario Ramo\u0301n y Cajal and Universidad de Alcala\u0301, E-28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Marti\u0301nez-Bermejo","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (M.L.-R., F.A.-B., J.I.B.-C., E.M.-B., H.F.E.-M.), Hospital Universitario Ramo\u0301n y Cajal and Universidad de Alcala\u0301, E-28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Lasuncio\u0301n","sequence":"additional","affiliation":[{"name":"Department of Centro de Investigacio\u0301n Biome\u0301dica en Red (CIBER) Fisiopatologia Obesidad y Nutricio\u0301n (CB06\/03) (M.A.L.), Instituto de Salud Carlos III, E-28029 Madrid, Spain"},{"name":"Department of Biochemistry-Research (M.A.L.), Hospital Universitario Ramo\u0301n y Cajal and Universidad de Alcala\u0301, E-28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He\u0301ctor F.","family":"Escobar-Morreale","sequence":"additional","affiliation":[{"name":"Departments of Endocrinology (M.L.-R., F.A.-B., J.I.B.-C., E.M.-B., H.F.E.-M.), Hospital Universitario Ramo\u0301n y Cajal and Universidad de Alcala\u0301, E-28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113571976400_R1","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"key\n\t\t\t\t2019041113571976400_R2","first-page":"25","article-title":"Prevalence, definition and clinical manifestations of polycystic ovary syndrome","volume":"53","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Endocrinol Nutr"},{"key":"key\n\t\t\t\t2019041113571976400_R3","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline.","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/er.2004-0004","article-title":"The molecular-genetic basis of functional hyperandrogenism and polycystic ovary syndrome.","volume":"26","author":"Escobar-Morreale","year":"2005","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113571976400_R5","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome.","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"key\n\t\t\t\t2019041113571976400_R6","first-page":"49","article-title":"Insulin resistance, obesity and metabolic syndrome in polycystic ovary syndrome","volume":"53","author":"Gambineri","year":"2006","journal-title":"Endocrinol Nutr"},{"key":"key\n\t\t\t\t2019041113571976400_R7","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.","volume":"166","author":"Alvarez-Blasco","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113571976400_R8","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113571976400_R9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2003-0004","article-title":"Polycystic ovary syndrome and cardiovascular disease: a premature association?","volume":"24","author":"Legro","year":"2003","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113571976400_R10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113571976400_R11","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome.","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t2019041113571976400_R13","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2337\/dc06-0877","article-title":"Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study.","volume":"29","author":"Lo","year":"2006","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113571976400_R14","first-page":"3389","article-title":"Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.","volume":"82","author":"Rajkhowa","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2006-1705","article-title":"Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.","volume":"92","author":"Berneis","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0895-4356(98)00010-9","article-title":"Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study.","volume":"51","author":"Talbott","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t2019041113571976400_R17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t2019041113571976400_R18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.","volume":"91","author":"Lo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R19","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1043-2760(02)00612-4","article-title":"The role of lifestyle modification in polycystic ovary syndrome.","volume":"13","author":"Norman","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R22","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome.","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113571976400_R23","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2002-021528","article-title":"A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills.","volume":"88","author":"Diamanti-Kandarakis","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R24","first-page":"CD005552","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","volume":"Rev","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst"},{"key":"key\n\t\t\t\t2019041113571976400_R25","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadzki","year":"1992","journal-title":"In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications;"},{"key":"key\n\t\t\t\t2019041113571976400_R26","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management.","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"key\n\t\t\t\t2019041113571976400_R27","article-title":"Terminology and differential diagnosis of genital tract bleeding in women","author":"Goodman","year":"1999"},{"key":"key\n\t\t\t\t2019041113571976400_R28","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0015-0282(97)00336-1","article-title":"Circulating leptin concentrations in women with hirsutism.","volume":"68","author":"Escobar-Morreale","year":"1997","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113571976400_R29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0015-0282(00)00718-4","article-title":"Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity.","volume":"74","author":"Escobar-Morreale","year":"2000","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019041113571976400_R30","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum.","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R31","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113571976400_R32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2337\/diacare.17.2.152","article-title":"A mathematical model for the determination of total area under glucose tolerance and other metabolic curves.","volume":"17","author":"Tai","year":"1994","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041113571976400_R33","first-page":"3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus.","volume-title":"Diabetes Care","author":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2003"},{"key":"key\n\t\t\t\t2019041113571976400_R34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"key\n\t\t\t\t2019041113571976400_R35","first-page":"3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report.","volume-title":"Circulation","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002"},{"key":"key\n\t\t\t\t2019041113571976400_R36","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R38","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1056\/NEJM198911093211907","article-title":"High-density lipoprotein\u2013the clinical implications of recent studies.","volume":"321","author":"Gordon","year":"1989","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113571976400_R39","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.1.01840","article-title":"Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.","volume":"152","author":"Rautio","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113571976400_R41","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0002-8703(87)90633-8","article-title":"Regulation of hepatic lipase and serum lipoproteins by sex steroids.","volume":"113","author":"Tikkanen","year":"1987","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t2019041113571976400_R42","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/0003-4819-128-6-199803150-00008","article-title":"Epidemiology of oral contraceptives and cardiovascular disease.","volume":"128","author":"Chasan-Taber","year":"1998","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113571976400_R43","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1210\/jc.2004-1958","article-title":"Association between the current use of low-dose oral contraceptives and cardiovascular arterial disease: a meta-analysis.","volume":"90","author":"Baillargeon","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113571976400_R44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/13625180400007751","article-title":"Ethinyl estradiol\/cyproterone acetate in polycystic ovary syndrome: lipid and carbohydrate changes.","volume":"9","author":"Villaseca","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"key\n\t\t\t\t2019041113571976400_R45","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","volume":"Rev","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst"},{"key":"key\n\t\t\t\t2019041113571976400_R46","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(03)13493-9","article-title":"Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome.","volume":"361","author":"Harborne","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113571976400_R47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients.","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/7\/2453\/11059078\/jcem2453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T10:01:41Z","timestamp":1587463301000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/7\/2453\/2598116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,1]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-0282","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,1]]}}}